AI assistant
Sending…
Ensysce Biosciences, Inc. — Director's Dealing 2017
Dec 2, 2017
35337_dirs_2017-12-01_55bacdf4-f7ed-4f48-a72f-4a2dac1dbece.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Leisure Acquisition Corp. (LACQ)
CIK: 0001716947
Period of Report: 2017-12-01
Reporting Person: Falcone Marc J. (Director)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 25000 | Direct |
More from Ensysce Biosciences, Inc.
Share Issue/Capital Change
2026
Jun 4
Delisting Announcement
2026
May 22
Interim / Quarterly Report
2026
May 15
Earnings Release
2026
May 15
Regulatory Filings
2026
Mar 23
Delisting Announcement
2026
Feb 27
Declaration of Voting Results & Voting Rights Announcements
2026
Jan 8
Proxy Solicitation & Information Statement
2025
Dec 16
Regulatory Filings
2025
Dec 12
Capital/Financing Update
2025
Dec 2